ModelEdge

Barinthus Biotherapeutics
BRNS
Filing Type8-K
Filing Date1/9/2025
Updated1/10/25, 6:02 AM

Filing

8-K
Earnings Release

Exhibits

8-KFinancial Results, Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation, Reg. FD
EX-99.1Financial Results, Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation, Reg. FD
EX-99.2Financial Results, Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation, Reg. FD
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC